The agency’s letter to the Marlborough-based medical device company's (Nasdaq: HOLX) CEO, Stephen MacMillan, which was made public on Tuesday, said the FDA found that the company’s BioZorb ...

Moderna Inc. entered the new year on the heels of a worsening stock performance in 2024. The Cambridge drugmaker’s stock dropped even further after lowering its expected revenue range for 2025 ...

MARLBOROUGH, Conn. (WTNH) — Multiple fire departments helped battle a house fire in Marlborough early Monday morning, officials said. Fire officials said crews arrived at the scene at around 5 a ...

MARLBOROUGH, CT (WFSB) - A firefighter was transported to a hospital during a house fire battle in Marlborough on Monday. The scene was on Jones Hollow Road. Fire officials said the fire broke out ...

Crews have responded to a house fire in Marlborough on Monday morning. The fire was reported around 5 a.m. at a home on Jones Hollow Road. Authorities have not released any details about the size ...

Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...

Moderna has lowered 2025 revenue guidance after a tough 2024 coronavirus vaccination season. However, the company aims to launch 10 new products over the next few years -- and that could lead to ...

Marlborough, Massachusetts--(Newsfile Corp. - January 14, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL ...

A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.

Earlier this month, Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s lackluster vaccine sales in COVID-19 and respiratory ...

Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence. The maker of vaccines, including the mRNA vaccine for COVID-19 ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...